Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer

Panitumumab is the first fully human monoclonal antibody to Epidermal Growth Factor Receptor (EGFR) to enter clinical trials for the treatment of solid tumors. The anti-tumor activity of panitumumab has been tested in vitro and in vivo, and inhibition of tumor growth has been observed in numerous ca...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Berardi, Rossana, Onofri, Azzurra, Pistelli, Mirco, Maccaroni, Elena, Scartozzi, Mario, Pierantoni, Chiara, Cascinu, Stefano
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2010
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2963923/
https://ncbi.nlm.nih.gov/pubmed/21042543
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki